血液系统移植患者鼻窦炎的疾病负担:全国性视角
该研究基于美国全国住院患者样本数据库2012至2013年数据,回顾性分析7,069例血液系统移植病例,其中2.7%合并鼻窦炎诊断。结果显示合并鼻窦炎者移植后住院时间更长、总住院费用更高,但两组死亡率无差异;接受鼻窦手术者住院时间和费用进一步增加。
要点
- 血液系统移植患者中鼻窦炎患病率为2.7%。
- 合并鼻窦炎者移植后住院时间延长、总住院费用增加,死亡率无差异。
- 合并鼻窦炎者接受鼻窦手术则住院时间和费用进一步增加。
核心结论
- 血液系统移植患者合并鼻窦炎与移植后住院时间延长和总住院费用增加相关。
- 建议在移植入院前加强鼻窦炎的诊断并尽可能治疗,以减少移植后影响。
研究设计与样本
- 回顾性分析美国全国住院患者样本数据库2012至2013年数据。
- 采用ICD-9-CM编码识别接受血液系统移植的患者,共7,069例。
- 按是否合并急性或慢性鼻窦炎诊断分为两组进行比较。
主要发现
- 7,069例血液系统移植病例中2.7%合并鼻窦炎诊断。
- 合并鼻窦炎者移植后住院时间24.9±15.9天,长于无鼻窦炎者的19.1±17.4天(P<.001)。
- 合并鼻窦炎者总住院费用$487,941±$447,532,高于无鼻窦炎者的$322,300±$369,596(P<.001)。
- 两组死亡率无差异(P=.75)。
- 23例(12%)合并鼻窦炎者接受鼻窦手术,其移植后住院时间34.8±25天 vs 23.5±13.7天(P=.001),总住院费用$857,891±$718,456 vs $437,293±$372,075(P<.001),均高于未手术的鼻窦炎患者。
临床怎么用
- 对拟行血液系统移植的患者,应关注鼻窦炎的诊断,并尽可能在移植前进行治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To determine the impact of sinusitis on outcomes of hematologic transplant procedures. STUDY DESIGN: Retrospective analysis of a national hospital database. METHODS: The National Inpatient Sample database for 2012 to 2013 was queried using International Classification of Diseases, Ninth Revision, Clinical Modification codes to identify patients undergoing hematologic transplants. Patients were divided based upon the presence or absence of a concomitant diagnosis of acute or chronic sinusitis. Patient demographics, clinical characteristics, discharge results, lengths of stay (LOS), and costs were compared between groups. RESULTS: There were 7,069 hematologic transplant cases identified, 2.7% of which had a diagnosis of sinusitis. Sinusitis patients had a longer LOS after transplant (24.9 ± 15.9 days vs. 19.1 ± 17.4 days, P < .001) and higher total hospital charges ($487,941 ± $447,532 vs. $322,300 ± $369,596, P < .001) than nonsinusitis patients. There was no difference in mortality between the two groups (P = .75). The 23 (12%) sinusitis patients who underwent sinus procedures had a longer LOS after transplant (34.8 ± 25 days vs. 23.5 ± 13.7 days, P = .001) and higher total hospital charges ($857,891 ± $718,456 vs. $437,293 ± $372,075, P < .001) than sinusitis patients without sinus procedures. Linear regression showed that sinusitis patients had excess LOS after transplant of 2.442 days and cost of $82,000.098. CONCLUSIONS: This study demonstrates that presence of sinusitis in patients undergoing hematologic transplant is associated with increased LOS and higher total hospital charges. Increased focus on diagnosis and if possible treatment of sinusitis prior to admission for transplantation may help reduce the impact of sinusitis after hematologic transplant. LEVEL OF EVIDENCE: NA Laryngoscope, 128:2688-2692, 2018.
引用
- Pandrangi V, Reiter ER. The Burden of Sinusitis in Hematologic Transplant Patients: A National Perspective. Laryngoscope. 2018. PMID: 30239988. doi:10.1002/lary.27363
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。